Bruker Corporation (Nasdaq: BRKR, BRKRP) today announced that its Board of Directors ("Board") has approved payment of a ...

Bruker (NASDAQ: BRKR) published its latest quarterly earnings report Monday morning, and despite notching a double beat the ...

According to a filing with the Securities and Exchange Commission released on Tuesday, Lane Generational sold its entire ...

Bruker Corporation (NASDAQ: BRKR) delivered a sharp earnings beat this morning, lifting shares nearly 7% despite underlying ...

Q3 2025 Earnings Call Transcript November 3, 2025 Bruker Corporation beats earnings expectations. Reported EPS is $0.6, ...

Bruker’s stock price target has recently seen a slight uptick, with consensus analyst forecasts rising from $46.73 to $47.82. This modest increase signals renewed analyst confidence in the company’s ...

Analysts are estimating that Bruker will report an earnings per share (EPS) of $0.33. Bruker bulls will hope to hear the ...

NYSBC has placed an order for the first Multifield NMR Relaxometry System in North America. In contrast, NSF funding has been ...

Investors in Bruker Corporation BRKR need to pay close attention to the stock based on moves in the options market lately.

Bruker’s MALDI Biotyper CA System wins FDA clearance for new software, faster workflows and 549 validated species.

BALTIMORE--(BUSINESS WIRE)-- At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ...

Bruker’s stock declined as the company lowered its full-year 2025 guidance, now expecting adjusted EPS of $1.85 to $1.90, below the analyst consensus of $1.94. The company projects annual revenue ...